Molecular Diagnosis & Therapy

Papers
(The TQCC of Molecular Diagnosis & Therapy is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
ADORA3: A Key Player in the Pathogenesis of Intracranial Aneurysms and a Potential Diagnostic Biomarker127
Predictive Ability of Serum Amino Acid Levels to Differentiate Fibromyalgia Patients from Healthy Subjects85
Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors71
Clinical Exome Reanalysis: Current Practice and Beyond56
Molecular Therapy for Choroideremia: Pre-clinical and Clinical Progress to Date55
A Window of Opportunity for Newborn Screening46
Comment on “Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta‑Analysis”46
Prognostic Biomarker-Based Identification of Drugs for Managing the Treatment of Endometrial Cancer43
Indirect Clinical Validation of a Programmed Death-Ligand 1 Laboratory-Developed Test for Gastric/Gastroesophageal Junction Adenocarcinoma with 22C3 Antibody Concentrate41
Personalized Cancer Monitoring Assay for the Detection of ctDNA in Patients with Solid Tumors38
Gene Therapy for Cardiomyocyte Renewal: Cell Cycle, a Potential Therapeutic Target38
Expression Signature of Immune-Related MicroRNAs in Autoimmune Skin Disease: Psoriasis and Vitiligo Insights33
Piflufolastat F 18: Diagnostic First Approval31
FAPI-Targeted Molecular Imaging: Transforming Insights into Post-Ischemic Myocardial Remodeling?31
Prediction of Biomarker Expression on Primary Pancreatic Ductal Adenocarcinoma Tissues Using Fine-Needle Biopsies: Paving the Way for a Patient-Tailored Molecular Imaging Approach30
Evaluation of Minimal Residual Disease in Patients with Neuroblastoma30
Drug Hypersensitivity Reactions in Patients with Cystic Fibrosis: Potential Value of the Lymphocyte Toxicity Assay to Assess Risk26
Glioma 2021 WHO Classification: The Superiority of NGS Over IHC in Routine Diagnostics24
Personalizing Oncolytic Immunovirotherapy Approaches24
Advances and Challenges in the Diagnosis of Leishmaniasis24
Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Central Nervous System Infections: Advances and Challenges23
Inflammatory Gene Panel Guiding the Study of Genetics in Inflammatory Bowel Disease23
Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders22
Transcript-Based Diagnosis and Expanded Phenotype of an Intronic Mutation in TPM3 Myopathy21
Afamitresgene Autoleucel: First Approval21
Comment on “The Diagnostic and Prognostic Value of miR‑155 in Cancers: An Updated Meta‑analysis”20
Diagnosis of Lung Cancer Through Exhaled Breath: A Comprehensive Study18
Smart PROTACs Enable Controllable Protein Degradation for Precision Cancer Therapy18
MET-Targeted Therapies and Clinical Outcomes: A Systematic Literature Review18
Molecular Therapeutics in Development to Treat Alzheimer’s Disease17
Advances in Pompe Disease Treatment: From Enzyme Replacement to Gene Therapy17
Development of a New Rapid Simultaneous Molecular Assay for the Detection of STI Pathogens and Drug Resistance-Associated Mutations17
Current and Emerging Applications of Droplet Digital PCR in Oncology: An Updated Review16
Targeted Therapy in Salivary Gland Cancer: Prevalence of a Selected Panel of Actionable Molecular Alterations in a German Tertiary Referral Center Patient Cohort16
The Road Traveled and Journey Ahead for the Genetics and Genomics of Tinnitus15
Single Nucleotide Variants in KIF14 Gene May Have Prognostic Value in Breast Cancer15
Performance of a Rapid Digital PCR Test for the Detection of Non-Small Cell Lung Cancer (NSCLC) Variants15
Molecular Dynamics as a Precision Therapy: A Perspective on Epileptic Encephalopathies15
The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta-analysis14
Achromatopsia: Genetics and Gene Therapy14
In vivo LNP-CRISPR Approaches for the Treatment of Hemophilia14
Preimplantation Genetic Testing for Monogenic Conditions: Is Cell-Free DNA Testing the Next Step?13
Lifileucel: First Approval13
Correction to: Molecular Therapeutics in Development to Treat Alzheimer’s Disease13
Is the Homologous Recombination Repair Mutation Defined by a 15-Gene Panel Associated with the Prognosis of Epithelial Ovarian Cancer?13
Cardiovascular Pharmacogenomics: An Update on Clinical Studies of Antithrombotic Drugs in Brazilian Patients13
Selecting Targets for Molecular Imaging of Gastric Cancer: An Immunohistochemical Evaluation12
Correction: Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders12
Role of lncRNAs in Remodeling of the Coronary Artery Plaques in Patients with Atherosclerosis12
Celomic Fluid: Laboratory Workflow for Prenatal Diagnosis of Monogenic Diseases12
Correction to: Analytical and Clinical Performance of Droplet Digital PCR in the Detection and Quantification of SARS-CoV-211
The Role οf Ion Channels in the Development and Progression of Prostate Cancer11
Comment on “Prognostic Value of Programmed Death Ligand-1 Expression in Solid Tumors Irrespective of Immunotherapy Exposure: A Systematic Review and Meta‑Analysis”11
Correction to: Optimization of a Quantitative PCR Methodology for Detection of Aspergillus spp. and Rhizopus arrhizus11
Bridging the Gap: Cost-Effective Strategies for Detecting Ph-Like B-Lineage ALL in Resource-Limited Settings11
Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab10
Psoriasis: A Multidimensional Review of Onset, Progression, Treatment, and the Evolution of Disease Models10
Fluorescence Imaging-Assessed Surgical Margin Detection in Head and Neck Oncology by Passive and Active Targeting10
Extracellular Histones Profiles of Pediatric H3K27-Altered Diffuse Midline Glioma10
Correction to: Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of R10
Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of “Second Hit” in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma10
Emerging RNAi Therapies to Treat Hypertension10
Obecabtagene Autoleucel: First Approval9
Author reply to Wang et al.: “The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta‑analysis”9
Future Prospects for Epigenetics in Autism Spectrum Disorder9
Blood Biomarkers of Long COVID: A Systematic Review9
Inner Ear Gene Therapy: An Overview from Bench to Bedside9
0.14728307723999